Cargando…

PMX464, a thiol-reactive quinol and putative thioredoxin inhibitor, inhibits NF-κB-dependent proinflammatory activation of alveolar epithelial cells

BACKGROUND AND PURPOSE: Subtle changes in the intracellular reduction–oxidation (redox) state can modulate nuclear factor-κB (NF-κB) activity. Thioredoxin-1 (Trx) is a small, ubiquitous, redox-active thiol (-SH) protein that, with thioredoxin reductase-1 (TrxR), modifies the redox status of NF-κB pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Callister, M E, Pinhu, L, Catley, M C, Westwell, A D, Newton, R, Leaver, S K, Quinlan, G J, Evans, T W, Griffiths, M J, Burke-Gaffney, A
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2008
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2442904/
https://www.ncbi.nlm.nih.gov/pubmed/18587424
http://dx.doi.org/10.1038/bjp.2008.258
_version_ 1782156741574656000
author Callister, M E
Pinhu, L
Catley, M C
Westwell, A D
Newton, R
Leaver, S K
Quinlan, G J
Evans, T W
Griffiths, M J
Burke-Gaffney, A
author_facet Callister, M E
Pinhu, L
Catley, M C
Westwell, A D
Newton, R
Leaver, S K
Quinlan, G J
Evans, T W
Griffiths, M J
Burke-Gaffney, A
author_sort Callister, M E
collection PubMed
description BACKGROUND AND PURPOSE: Subtle changes in the intracellular reduction–oxidation (redox) state can modulate nuclear factor-κB (NF-κB) activity. Thioredoxin-1 (Trx) is a small, ubiquitous, redox-active thiol (-SH) protein that, with thioredoxin reductase-1 (TrxR), modifies the redox status of NF-κB pathway components. PMX464 is a novel thiol-reactive quinol thought to inhibit the Trx/TrxR system. The aim of this work was to investigate whether PMX464 inhibited NF-κB-mediated proinflammatory activation of human type II alveolar epithelial cells (A549). EXPERIMENTAL APPROACH: Intercellular adhesion molecule-1 (ICAM-1), granulocyte-macrophage colony-stimulating factor (GM-CSF) and CXCL8, NF-κB DNA binding, nuclear translocation of NF-κB p65 subunit, IκBα degradation, IκB phosphorylation and IκB kinase (IKK) activity were assessed in A549 cells stimulated with IL-1β with or without PMX464 pretreatment. Effects of PMX464 on ICAM-1 expression in human lung microvascular endothelial cells (HLMVEC) were also investigated. For comparison, selected measurements (ICAM-1 and IκB-α phospho-IκB-α) were made on A549 cells after RNA interference-mediated silencing (siRNA) of Trx. KEY RESULTS: PMX464 reduced ICAM-1, GM-CSF and CXCL8 expression in IL-1β-stimulated A549 cells and ICAM-1 in HLMVEC. PMX464 inhibited IL-1β-induced NF-κB DNA binding, nuclear translocation of NF-κB p65 subunit and factors involved in NF-κB activation; specifically, IκBα degradation, IκB phosphorylation and IκB kinase (IKK) activity in A549. By contrast, Trx siRNA did not alter ICAM-1 expression or IκBα degradation/phosphorylation in IL-1β-stimulated A549 cells. CONCLUSION AND IMPLICATIONS: PMX464 inhibits a proinflammatory response in A549 cells targeting the NFκB pathway above IKK. The lack of effect with Trx siRNA suggests that PMX464 acts on thiol proteins, in addition to Trx, to elicit anti-inflammatory responses in lung epithelial cells.
format Text
id pubmed-2442904
institution National Center for Biotechnology Information
language English
publishDate 2008
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-24429042008-07-03 PMX464, a thiol-reactive quinol and putative thioredoxin inhibitor, inhibits NF-κB-dependent proinflammatory activation of alveolar epithelial cells Callister, M E Pinhu, L Catley, M C Westwell, A D Newton, R Leaver, S K Quinlan, G J Evans, T W Griffiths, M J Burke-Gaffney, A Br J Pharmacol Research Papers BACKGROUND AND PURPOSE: Subtle changes in the intracellular reduction–oxidation (redox) state can modulate nuclear factor-κB (NF-κB) activity. Thioredoxin-1 (Trx) is a small, ubiquitous, redox-active thiol (-SH) protein that, with thioredoxin reductase-1 (TrxR), modifies the redox status of NF-κB pathway components. PMX464 is a novel thiol-reactive quinol thought to inhibit the Trx/TrxR system. The aim of this work was to investigate whether PMX464 inhibited NF-κB-mediated proinflammatory activation of human type II alveolar epithelial cells (A549). EXPERIMENTAL APPROACH: Intercellular adhesion molecule-1 (ICAM-1), granulocyte-macrophage colony-stimulating factor (GM-CSF) and CXCL8, NF-κB DNA binding, nuclear translocation of NF-κB p65 subunit, IκBα degradation, IκB phosphorylation and IκB kinase (IKK) activity were assessed in A549 cells stimulated with IL-1β with or without PMX464 pretreatment. Effects of PMX464 on ICAM-1 expression in human lung microvascular endothelial cells (HLMVEC) were also investigated. For comparison, selected measurements (ICAM-1 and IκB-α phospho-IκB-α) were made on A549 cells after RNA interference-mediated silencing (siRNA) of Trx. KEY RESULTS: PMX464 reduced ICAM-1, GM-CSF and CXCL8 expression in IL-1β-stimulated A549 cells and ICAM-1 in HLMVEC. PMX464 inhibited IL-1β-induced NF-κB DNA binding, nuclear translocation of NF-κB p65 subunit and factors involved in NF-κB activation; specifically, IκBα degradation, IκB phosphorylation and IκB kinase (IKK) activity in A549. By contrast, Trx siRNA did not alter ICAM-1 expression or IκBα degradation/phosphorylation in IL-1β-stimulated A549 cells. CONCLUSION AND IMPLICATIONS: PMX464 inhibits a proinflammatory response in A549 cells targeting the NFκB pathway above IKK. The lack of effect with Trx siRNA suggests that PMX464 acts on thiol proteins, in addition to Trx, to elicit anti-inflammatory responses in lung epithelial cells. Nature Publishing Group 2008-06-30 2008-11 /pmc/articles/PMC2442904/ /pubmed/18587424 http://dx.doi.org/10.1038/bjp.2008.258 Text en Copyright 2008, Nature Publishing Group http://creativecommons.org/licenses/by-nc-nd/3.0/ This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivs 3.0 License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/.
spellingShingle Research Papers
Callister, M E
Pinhu, L
Catley, M C
Westwell, A D
Newton, R
Leaver, S K
Quinlan, G J
Evans, T W
Griffiths, M J
Burke-Gaffney, A
PMX464, a thiol-reactive quinol and putative thioredoxin inhibitor, inhibits NF-κB-dependent proinflammatory activation of alveolar epithelial cells
title PMX464, a thiol-reactive quinol and putative thioredoxin inhibitor, inhibits NF-κB-dependent proinflammatory activation of alveolar epithelial cells
title_full PMX464, a thiol-reactive quinol and putative thioredoxin inhibitor, inhibits NF-κB-dependent proinflammatory activation of alveolar epithelial cells
title_fullStr PMX464, a thiol-reactive quinol and putative thioredoxin inhibitor, inhibits NF-κB-dependent proinflammatory activation of alveolar epithelial cells
title_full_unstemmed PMX464, a thiol-reactive quinol and putative thioredoxin inhibitor, inhibits NF-κB-dependent proinflammatory activation of alveolar epithelial cells
title_short PMX464, a thiol-reactive quinol and putative thioredoxin inhibitor, inhibits NF-κB-dependent proinflammatory activation of alveolar epithelial cells
title_sort pmx464, a thiol-reactive quinol and putative thioredoxin inhibitor, inhibits nf-κb-dependent proinflammatory activation of alveolar epithelial cells
topic Research Papers
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2442904/
https://www.ncbi.nlm.nih.gov/pubmed/18587424
http://dx.doi.org/10.1038/bjp.2008.258
work_keys_str_mv AT callisterme pmx464athiolreactivequinolandputativethioredoxininhibitorinhibitsnfkbdependentproinflammatoryactivationofalveolarepithelialcells
AT pinhul pmx464athiolreactivequinolandputativethioredoxininhibitorinhibitsnfkbdependentproinflammatoryactivationofalveolarepithelialcells
AT catleymc pmx464athiolreactivequinolandputativethioredoxininhibitorinhibitsnfkbdependentproinflammatoryactivationofalveolarepithelialcells
AT westwellad pmx464athiolreactivequinolandputativethioredoxininhibitorinhibitsnfkbdependentproinflammatoryactivationofalveolarepithelialcells
AT newtonr pmx464athiolreactivequinolandputativethioredoxininhibitorinhibitsnfkbdependentproinflammatoryactivationofalveolarepithelialcells
AT leaversk pmx464athiolreactivequinolandputativethioredoxininhibitorinhibitsnfkbdependentproinflammatoryactivationofalveolarepithelialcells
AT quinlangj pmx464athiolreactivequinolandputativethioredoxininhibitorinhibitsnfkbdependentproinflammatoryactivationofalveolarepithelialcells
AT evanstw pmx464athiolreactivequinolandputativethioredoxininhibitorinhibitsnfkbdependentproinflammatoryactivationofalveolarepithelialcells
AT griffithsmj pmx464athiolreactivequinolandputativethioredoxininhibitorinhibitsnfkbdependentproinflammatoryactivationofalveolarepithelialcells
AT burkegaffneya pmx464athiolreactivequinolandputativethioredoxininhibitorinhibitsnfkbdependentproinflammatoryactivationofalveolarepithelialcells